SEMA4
LIVE

Serial Number

86983080

Owner

MOUNT SINAI GENOMICS, INC.

Attorney

Aaron D. Hendelman

First Use Date

May 1, 2017

Filing Date

Jun 11, 2015

Add to watchlist:

No watchlists yet
View on USPTO

SEMA4 Trademark

Serial Number: 86983080 • Registration: 5330559

SEMA4 is a trademark filed by MOUNT SINAI GENOMICS, INC. on June 11, 2015. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

MOUNT SINAI GENOMICS, INC. (11 trademarks)

1425 MADISON AVENUE
NEW YORK, NY 10029

Entity Type: 03

Icahn School of Medicine at Mount Sinai (4 trademarks)

One Gustave L. Levy Place
New York, NY 10029

Entity Type: 99

SEMA4 OPCO, INC. (9 trademarks)

333 Ludlow Street
Stamford, CT 06902

Entity Type: 03

Trademark Details

Filing Date

June 11, 2015

Registration Date

November 7, 2017

First Use Anywhere

May 1, 2017

First Use in Commerce

May 1, 2017

Published for Opposition

January 19, 2016

Goods & Services

[ Kits containing chemical and biochemical assays and reagents for scientific research use; nucleic acid and protein isolation kits comprised primarily of assays and reagents for use in epigenetic research and analysis; none of the aforementioned involve the use or study of semaphorins ]

Diagnostic services in the field of medicine; medical testing for diagnosis of diseases and treatment purposes [; bioinformatics analysis for medical diagnostic and personalized treatment purposes; biochemical testing for ancestry analysis and personalized diagnostics and treatments; nucleic acid analysis and screening for medical diagnostic and treatment purposes; DNA analysis and screening for medical diagnostic and treatment purposes; consulting services in the field of biological sequence and bioinformatic processing for medical diagnosis and treatment purposes; health care services, namely, leveraging health monitoring and data science to provide optimal health and disease prevention to patients; creating personalized preventative health-care programs and disease management programs; providing an online resource center featuring personalized health information based on health information and diagnostics; medical testing, namely, identifying drug targets for diagnostic or treatment purposes; none of the aforementioned involve the use or study of semaphorins ]

[ Medical and scientific research in the field of biologic testing and interpretation, diagnosis, treatment, and health maintenance; bioinformatics interpretation of health data; medical and scientific research in the field of ancestry analysis for scientific research purposes; compiling data for research purposes in the field of medical science and medical consultancy for use in connection with diagnostic testing; analysis and screening of nucleic acids for scientific research purposes; genome mapping for scientific purposes; ] providing information in the field of disease classification for use in connection with diagnostic testing [; development of scientific research and technology for purposes of disease diagnosis, preventative health care, health monitoring, and personalized treatment; providing a website featuring non-downloadable software for patient access to health care services and health information; providing a website featuring non-downloadable software for patient access to diagnosis, treatment, and health maintenance information; providing a website featuring non-downloadable software for accessing, viewing, interacting with and downloading personal health records, diagnoses, treatment plans, and health monitoring information; scientific and medical research, namely, identifying drug targets; scientific research relating to population health management; none of the aforementioned involve the use or study of semaphorins ]

[ Business consulting and business information services regarding precision health diagnosis and personalized treatment; business consulting and business information services regarding the analysis and packaging of health data; providing business information, namely, commercial corporate and statistical information provided on-line from a computer database or the Internet; statistical analysis and reporting services for business purposes; business consulting and business information services regarding the identification of drug targets; business consulting and business information services regarding bioinformatic analysis; population health management ]

[ Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases, namely, cancer and Mendelian disorders; test kits consisting of medical diagnostic reagents and assays for testing in the field of the prevention and treatment of disorders and diseases; none of the aforementioned involve the use or study of semaphorins ]

Filing History

WITHDRAWAL OF ATTORNEY GRANTED
Jun 1, 2026 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Jun 1, 2026 WOAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 1, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 1, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 1, 2025 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Jan 30, 2025 NAS8
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
Jan 30, 2025 8.PR
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
Jan 30, 2025 PRAN
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 30, 2025 APRE
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Oct 28, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 28, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 28, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 28, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 28, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 28, 2024 COAR
TEAS SECTION 8 RECEIVED
May 7, 2024 ES8R
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Nov 8, 2023 ASCK
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 7, 2022 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 10, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 10, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 10, 2022 REAP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 4, 2021 ASGN
CORRECTION UNDER SECTION 7 - PROCESSED
May 7, 2018 COC.
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
May 7, 2018 EROP
POST REGISTRATION ACTION MAILED - SEC. 7
Dec 27, 2017 PRAM
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 27, 2017 APRE
FAX RECEIVED
Nov 27, 2017 FAXX
TEAS SECTION 7 REQUEST RECEIVED
Nov 20, 2017 ES7R
REGISTERED-PRINCIPAL REGISTER
Nov 7, 2017 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 30, 2017 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 29, 2017 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Sep 13, 2017 SUPC
DIVISIONAL PROCESSING COMPLETE
Sep 13, 2017 DPCC
USE AMENDMENT FILED
Sep 11, 2017 IUAF
DIVISIONAL REQUEST RECEIVED
Sep 11, 2017 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Sep 11, 2017 ERTD
TEAS STATEMENT OF USE RECEIVED
Sep 11, 2017 EISU
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 30, 2017 ASGN
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 17, 2017 EXRA
SOU EXTENSION 2 GRANTED
Mar 15, 2017 EX2G
SOU EXTENSION 2 FILED
Mar 15, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 15, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 30, 2016 EXRA
SOU EXTENSION 1 GRANTED
Nov 29, 2016 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 28, 2016 AITU
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 20, 2016 TCCA
NOTICE OF REVIVAL - E-MAILED
Oct 20, 2016 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
Oct 20, 2016 TPEX
PETITION TO REVIVE-GRANTED
Oct 20, 2016 PETG
TEAS PETITION TO REVIVE RECEIVED
Oct 20, 2016 PROA
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Oct 17, 2016 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 17, 2016 ABN6
SOU EXTENSION 1 FILED
Sep 15, 2016 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 15, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 19, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jan 19, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 30, 2015 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 15, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 10, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 8, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 8, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 16, 2015 GNRN
NON-FINAL ACTION E-MAILED
Jul 16, 2015 GNRT
NON-FINAL ACTION WRITTEN
Jul 16, 2015 CNRT
ASSIGNED TO EXAMINER
Jul 11, 2015 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Jun 16, 2015 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 15, 2015 NWOS
NEW APPLICATION ENTERED
Jun 15, 2015 NWAP